Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Feb;7(2):254-258.
doi: 10.1002/acn3.50979. Epub 2020 Jan 10.

Relapsing-remitting clinical course expands the phenotype of Aicardi-Goutières syndrome

Affiliations
Case Reports

Relapsing-remitting clinical course expands the phenotype of Aicardi-Goutières syndrome

Jeffrey Lambe et al. Ann Clin Transl Neurol. 2020 Feb.

Abstract

Aicardi-Goutières syndrome (AGS) is a rare and likely underdiagnosed genetic leukoencephalopathy, typically presenting in infancy with encephalopathy and characteristic neuroimaging features, with residual static neurological deficits. We describe a patient who, following an initial presentation at the age of 12 months in keeping with AGS, exhibited a highly atypical relapsing course of neurological symptoms in adulthood with essentially normal neuroimaging. Whole-exome sequencing confirmed a pathogenic RNASEH2B gene variant consistent with AGS. This case highlights the expanding phenotypes associated with AGS and the potential role of whole-exome sequencing in facilitating an increase in the rate of diagnosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
MRI findings. Neuroimaging (T2 fluid‐attenuated inversion recovery [FLAIR]) of the patient performed at 30 years of age (A–F: axial views [A–C: level of medulla oblongata, pons, and midbrain, respectively]; G–I: sagittal views), demonstrating scattered small foci of hyperintensity within the periventricular and subcortical white matter (indicated by arrows).

References

    1. Goutières F. Aicardi–Goutières syndrome. Brain Dev 2005;27:201–206. - PubMed
    1. Rice G, Patrick T, Parmar R, et al. Clinical and molecular phenotype of Aicardi‐Goutières syndrome. Am J Hum Genet 2007;81:713–725. - PMC - PubMed
    1. Svingen L, Goheen M, Godfrey R, et al. Late diagnosis and atypical brain imaging of Aicardi‐Goutières syndrome: are we failing to diagnose Aicardi‐Goutières syndrome‐2? Dev Med Child Neurol 2017;59:1307–1311. - PMC - PubMed
    1. Crow YJ, Chase DS, Lowenstein Schmidt J, et al. Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1 . Am J Med Genet 2015;167:296–312. - PMC - PubMed
    1. Crow Y, Zaki M, Abdel‐Hamid M, et al. Mutations in ADAR1, IFIH1, and RNASEH2B presenting as spastic paraplegia. Neuropediatrics 2014;45:386–391. - PubMed

Publication types

MeSH terms

Supplementary concepts